|
Home
CME Live Seminars
About the Program
Quick Order
Hotel Registration
Auto Rental
Accreditation
Cancellation Policy
Testimonials
CME Video DVD
CME Audio CD/MP3
Subscribe
Request Brochure
Hold Seat
Testing Online
Faculty
Resources
Contact Us
|
|
|
|
Live CME Seminars
Family Medicine CME |
|
|
by Kevin S. Ferentz, M.D. - University of Maryland School of Medicine; Associate Professor and Director of Clinical Operations, Department of Family & Community Medicine; Baltimore, MD; Lisa R. Ferentz, M.S.W., L.C.S.W.-C., DAPA - University of Maryland School of Medicine; Clinical Instructor and Faculty Member, Department of Family and Community Medicine; Founder and President, The Institute for Advanced Psychotherapy Training and Education, Inc.; Clinical Social Worker, Private Practice and Clinical Social Work Consultant, Baltimore, MD; Sharon Feinstein, M.D. - University of Maryland School of Medicine; Assistant Professor, Department of Family and Community Medicine; Baltimore, MD and Amit Golding, M.D., Ph.D. - National Institutes of Health/NIAID; Postdoctoral Fellow, Intramural Research Training Awards (IRTA), Cellular Immunology Section, Shevach Lab, Laboratory of Immunology; Bethesda, MD.
Learning Objectives
What do our past participants have to say?
Refer a Colleague to Our Website
|
|
Family Medicine: A Review and Update of Common Clinical Problems
June 20-24, 2011
Location: Hyatt Regency Sarasota, Florida
| SPECIFIC OBJECTIVES
| | Day 1 | Routine Adult Care - Upon completion of this session, the participant should be able to:
| 1. | Determine which screening tests are indicated for particular patients, according to USPSTF guidelines.
| | 2. | Order appropriate immunizations for adult patients.
| | An Approach to Caring for Adolescents - Upon completion of this session, utilizing resources and guidelines from the CDC, USPSTF, AAP, and AAFP, the participant should be able to:
| | 1. | Identify the leading causes of adolescent morbidity and mortality.
| | 2. | Employ preventative health recommendations to identify and address behaviors leading to adolescent morbidity including drug, alcohol, and tobacco use, risky sexual behaviors, poor nutrition and inadequate physical activity.
| | 3. | Apply current screening recommendation and examination essentials to the adolescent office visit.
| | Improving Compliance - Upon completion of this session, the participant should be able to:
| | 1. | Use techniques that can better detect non-compliance in their patients.
| | 2. | Apply techniques that can be used to increase compliance in their patients.
| | Asthma - Upon completion of this session, utilizing NHLBI guidelines, the participant should be able to:
| | 1. | Employ various methods to diagnosis asthma.
| | 2. | Evaluate impairment and risk of an asthmatic patient to determine severity and control of disease.
| | 3. | Develop a comprehensive approach to improving asthma outcomes including: identification and control of triggers and comorbid conditions, patient education regarding proper use of medications, and asthma action plans.
| | 4. | Apply the recommended stepwise approach to determine appropriate medications for treatment.
|
| | Day 2 | Coronary Artery Disease - Upon completion of this session, the participant should be able to:
| 1. | Assess patients presenting with chest pain in order to identify patients with potential coronary artery disease.
| | 2. | Develop an appropriate diagnostic evaluation for a patient with chest pain.
| | 3. | Determine which treatments - medical and surgical - are appropriate for individual patients.
| | Rheumatologic Lab Tests – Diagnosis, Prognosis & Management - Upon completion of this session, the participant should be able to:
| | 1. | Order the appropriate screening tests that may lead to a diagnosis in the correct clinical context, including acute phase proteins e.g. ESR/CRP, and specific antibodies, e.g. ANA, Rheumatoid Factor, and the newer anti-CCP.
| | 2. | Select additional lab tests to help broaden the differential diagnosis of common symptoms (e.g. TFTs for “fatigue”), to help determine disease activity (e.g. complements in SLE), and to help broaden the index of inflammation (e.g. Ferritin).
| | 3. | Order lab tests “in anticipation” of potential anti-rheumatic agents, e.g. Vitamin D levels prior to long-term prednisone; LFTs prior to methotrexate; and CK prior to colchicine.
| | Thyroid Disease. - Upon completion of this session, the participant should be able to:
| | 1. | Formulate a plan for the evaluation of a patient with presumed thyroid disease.
| | 2. | Interpret common lab and imaging tests in the evaluation of a patient with thyroid disease.
| | 3. | Select appropriate treatment modalities, both medical and surgical, for patients with thyroid disease.
| | Secondary Amenorrhea - Upon completion of this session, the participant should be able to:
| | 1. | Utilize a comprehensive algorithm for the evaluation of secondary amenorrhea.
| | 2. | Detect the most common causes of secondary amenorrhea (including pregnancy, thyroid disease, and hyperprolactinemia) and develop initial treatment plans.
| | 3. | Identify specific causes of normogonadotropic amenorrhea, hypergonadotropic hypogonadism, and hypogonadotropic hypogonadism to determine treatment approach.
|
| | Day 3 | Food for Thought: Understanding and Working with Eating Disorders - Upon completion of this session, the participant should be able to:
| 1. | Identify the behavioral and psychosocial triggers that promote eating disordered behaviors.
| | 2. | Distinguish between the symptoms of anorexia, bulimia and binge eating behaviors.
| | 3. | Recognize the clinical “red flags” that indicate eating disordered behavior.
| | 4. | Apply appropriate interventions designed to treat eating disordered behaviors.
| | Hypovitaminosis D - A Preventable Epidemic - Upon completion of this session, the participant should be able to:
| | 1. | Identify the possible causes of the high rate for Vitamin D deficiency among different U.S. patient populations.
| | 2. | Appraise the impact of Hypovitaminosis D on multiple health outcomes including bone mineral density, metabolic syndrome, cardiovascular disease, and all cause mortality.
| | 3. | Detect and treat both to correct Vitamin D insufficiency and successfully maintain appropriate Vitamin D levels for long-term health.
| | Anemia - Upon completion of this session, the participant should be able to:
| | 1. | Utilize the guidelines for diagnosing anemia in children and adults.
| | 2. | Develop a diagnostic strategy to ascertain the etiology of the anemia.
| | 3. | Describe the role of consultants in the evaluation and management of anemia.
| | Chronic Pelvic Pain - Upon completion of this session, the participant should be able to:
| | 1. | Distinguish the many etiologies of chronic pelvic pain.
| | 2. | Develop a clear and comprehensive approach to identifying the most likely cause of chronic pelvic pain in their patient utilizing recommended history questions, physical examination and diagnostic studies.
| | 3. | Determine appropriate management options for patient, including utilizing a multidisciplinary approach and specialty referral when needed.
|
| | Day 4 | Identification and Treatment of Traumatized Patients - Upon completion of this session, the participant should be able to:
| 1. | Describe the characteristics associated with traumatic events.
| | 2. | Interpret the “red flags” or symptomatic manifestations of trauma in patients.
| | 3. | Demonstrate how to obtain a trauma history from a patient during the H and P.
| | 4. | Identify and propose interventions designed to treat symptoms of trauma and increase comfort during physical exam.
| | Gout - Uric Acid as a Danger Signal - Upon completion of this session, the participant should be able to:
| | 1. | Formulate a plan of lifestyle and nutrition changes for patients with gout that reflects the connections between hyperuricemia, metabolic syndrome and increased risk of cardiovascular disease.
| | 2. | Prescribe treatment for acute attacks of gout as well as for prevention of recurrent gout flares with more effective use of standard therapy.
| | 3. | Assess new and “on-the-horizon” gout treatments based on cutting edge research linking hyperuricemia to the Inflammasome and IL-1.
| | Depression and Anxiety in Primary Care - Upon completion of this session, the participant should be able to:
| | 1. | Explain the incidence and prevalence of anxiety and depression.
| | 2. | Evaluate patients with signs and symptoms of anxiety and depression so as to make an accurate diagnosis.
| | 3. | Prescribe appropriate medications to treat these disorders.
| | Management of Diabetes - Upon completion of this session, based on the guidance of the American Diabetes Association, the American Society of Clinical Endocrinologists and American Association of Diabetes Educators, the participant should be able to:
| | 1. | Apply recommendations for screening and diagnosis of Type 2 diabetes mellitus.
| | 2. | Formulate treatment plans based on the current pharmacological treatment options.
| | 3. | Design individualized plans to optimize glycemic control by integrating self-management tools, patient goal setting and general principles of nutrition.
| | 4. | Utilize lessons learned from diabetes group visits to improve the care and satisfaction of diabetes patients.
|
| | Day 5 | Smoking Cessation - Upon completion of this session, the participant should be able to:
| 1. | Recognize the role of smoking in disease etiology.
| | 2. | Utilize techniques to enhance their patients' ability to stop smoking.
| | Osteoporosis - Upon completion of this session, the participant should be able to:
| | 1. | Identify conditions, diseases and medications that can cause or contribute to osteoporosis and fractures.
| | 2. | Apply the current recommendations for evaluating patients at identified risk for osteoporosis using USPSTF, WHO and NOF guidelines.
| | 3. | Utilize non-pharmacologic and lifestyle approaches to prevent bone loss and fracture.
| | 4. | Develop individualized treatment plans for patients based on risks and benefits of pharmacologic treatment options.
| | Obesity - Upon completion of this session, the participant should be able to:
| | 1. | State the epidemiology of obesity in America and the health risks associated with obesity.
| | 2. | Assess patients that are obese and that are in need of treatment.
| | 3. | Recommend and utilize various treatment options available, including diet, exercise, medications, and bariatric surgery.
| | Uncomplicated and Complicated Urinary Tract Infections - Upon completion of this session, using evidence-based guidelines of the IDSA and AUA, the participant should be able to:
| | 1. | Recognize the prevalence, epidemiology and socioeconomic impact of UTIs.
| | 2. | Discriminate the attributes of lower tract and upper tract infections, recurrent cystitis and infection relapses.
| | 3. | Assess risk factors for complicated UTIs including structural abnormalities, metabolic or hormonal disorders and immune defects.
| | 4. | Apply treatment principles to uncomplicated and complicated UTIs.
|
|
|